Prosecution Insights
Last updated: April 19, 2026
Application No. 18/672,351

Smart Mammography Image Acquisition System and Method

Non-Final OA §102
Filed
May 23, 2024
Examiner
GAWORECKI, MARK R
Art Unit
2884
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
GE Precision Healthcare LLC
OA Round
1 (Non-Final)
91%
Grant Probability
Favorable
1-2
OA Rounds
2y 1m
To Grant
98%
With Interview

Examiner Intelligence

Grants 91% — above average
91%
Career Allow Rate
1025 granted / 1128 resolved
+22.9% vs TC avg
Moderate +7% lift
Without
With
+6.6%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
23 currently pending
Career history
1151
Total Applications
across all art units

Statute-Specific Performance

§101
5.7%
-34.3% vs TC avg
§103
35.8%
-4.2% vs TC avg
§102
24.4%
-15.6% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1128 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 1, 4, 5, 9, 11, 14, and 16 are objected to under MPEP 608.01(m) for the use of periods within the claims. MPEP 608.01(m) states that, "Each claim begins with a capital letter and ends with a period. Periods may not be used elsewhere in the claims except for abbreviations. See Fressola v. Manbeck, 36 USPQ2d 1211 (D.D.C. 1995).” The Examiner suggests the use of “a), b), i), ii), etc.” in place of “a., b., i., ii, etc.” Claims 2-3, 6-8, 10, 12-13, 15, and 17-20 are objected to for reasons of dependency. With respect to claim 12, there is no antecedent basis for “the second compression”. This limitation appears to find antecedent basis in claim 5 rather than claim 4, from which this claim currently depends. Appropriate correction is required. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4, 8-11, 16-18, and 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Milioni De Carvalho, et al. (US 2021/0259649 A1, published 26 August 2021). With respect to claims 1-3, 16 and 17, Milioni De Carvalho discloses: a system and associated method for determining the need for generation of enhanced diagnostic images of a patient, the method comprising the steps of: a) providing an imaging system comprising: i) a radiation source operable at to emit radiation at multiple energy levels (low energy and high energy, par. [0031]), a detector alignable with the radiation source (18, par. [0021]), the detector having a surface on which an object to be imaged is adapted to be positioned (40, compression paddle, for example); and ii) a controller operably connected to the radiation source and the detector to control the operation of the radiation source and detector to generate image data in an imaging procedure performed by the imaging system, the controller including a central processing unit and interconnected database for processing the image data from the detector to create images (processor, par. [0074]), a display operably connected to the controller for presenting information to a user (50, par. [0025]), and a user interface operably connected to the controller to enable user input to the controller (52/54/56, par. [0025]); b) positioning the object on the surface between the radiation source and the detector; c) acquiring one or more low energy (LE) images of the object (scout scan images par. [0040]); d) analyzing the one or more LE images to locate one or more triggering attributes, characteristics or findings within the object (imaging in LE images may confound visualization of the legion, par. [0059]); e) optionally acquiring one or more additional images of the object, the one or more additional images acquired with radiation having an energy level different than employed for acquiring the one or more LE images if one or more triggering attributes, characteristics or findings are located in the object (subsequent imaging using DE imaging, which includes and HE image, par. [0061]); and f) optionally processing the one or more LE images and the one or more additional images to form one or more enhanced images (DE images, par. [0061], which may be 3D, par. [0073]). With respect to claims 4 and 20, Milioni De Carvalho discloses the claimed method wherein the imaging system is a mammography imaging system including a gantry supporting the radiation source and the detector and operably connected to the controller (shown in Fig. 1, par. [0023]), a compression plate disposed on the gantry and movable with respect to the radiation source and the detector, wherein the object is a breast (par. [0023]), wherein the one or more triggering attributes, characteristics or findings within the object are one or more regions of interest (ROIs) within the breast (lesion, par. [0059]) and wherein the step of positioning the object on the surface between the radiation source and the detector comprises the steps of: a) placing the breast on the surface of the detector; and b) moving the compression plate to compress the breast at a first compression between the compression plate and the surface (par. [0023]). With respect to claims 8-11 and 18, Milioni De Carvalho discloses that acquiring one or more LE images comprises the one or more LE images in a 2D or 3D acquisition procedure (par. [0015]), and acquiring the one or more HE images in a 2D or 3D acquisition procedure (par. [0032, 0057, 0070]. Allowable Subject Matter Claims 5-7, 12-15, and 19 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: With respect to claims 5-7 and 12 (see claim objection above), the cited prior art does not appear to disclose or reasonably suggest: a) moving the compression plate to decompress the breast from the first compression between the compression plate and the surface after acquiring the one or more LE images of the breast; and b) moving the compression plate to recompress the breast at a second compression between the compression plate and the surface, in addition to all of the other claimed elements. With respect to claim 13, the cited prior art does not appear to specify analyzing the one or more LE images manually through the user interface. With respect to claim 14, the cited prior art does not specify adjusting a collimator on the radiation source between acquisition of the LE images and one or more additional images, as claimed. With respect to claims 15 and 19, the cited prior art does not appear to specify automatically performing analysis of LE images by a CAD system, as clamed. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARK R GAWORECKI whose telephone number is (571)272-8540. The examiner can normally be reached Monday-Friday 8 AM-6 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, DAVID MAKIYA can be reached at 571-272-2273. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARK R GAWORECKI/ Primary Examiner, Art Unit 2884 19 December 2025
Read full office action

Prosecution Timeline

May 23, 2024
Application Filed
Dec 19, 2025
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12603266
DEVICE AND METHOD FOR HIGH POWER-DENSITY THERMIONIC ENERGY CONVERSION
2y 5m to grant Granted Apr 14, 2026
Patent 12597581
X-RAY GENERATION DEVICE
2y 5m to grant Granted Apr 07, 2026
Patent 12591075
RADIATION DETECTOR, METHOD FOR MANUFACTURING RADIATION DETECTOR, AND IMAGING METHOD
2y 5m to grant Granted Mar 31, 2026
Patent 12586672
INTELLIGENT TREATABLE SECTORS FOR RADIATION THERAPY PLAN GENERATION
2y 5m to grant Granted Mar 24, 2026
Patent 12582317
DETECTING DEVICE AND MEASURING APPARATUS
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
91%
Grant Probability
98%
With Interview (+6.6%)
2y 1m
Median Time to Grant
Low
PTA Risk
Based on 1128 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month